IP Library Granted Patent US 8,702,585
Granted Patent B2
US 8,702,585 · App. 11/981,597 · Granted Apr 22, 2014

Pelvic health implants and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,702,585
App. No.
11/981,597
Granted
Apr 22, 2014
Kind
B2
Abstract

Surgical articles, implants and components suitable for female pelvic health procedures are described.

Claims (27)

1. A method for treating a prolapse disorder, the method comprising:

providing an implant comprising a synthetic mesh material having a major portion adapted to support the patient's vaginal region, at least two projections extending from the major portion, and an anchor at an end of each projection,

positioning the major portion to support a vaginal region,

anchoring the anchor of one projection to a right obturator foramen, and

anchoring the anchor of another projection to a left obturator foramen.

2. The method of claim 1 wherein the disorder is selected from cystocele, rectocele, enterocele, vaginal vault prolapse, uterine prolapse, and anal prolapse.

3. The method of claim 1 comprising engaging the anchor with a surgical instrument.

4. The method of claim 1 comprising inserting the implant through a vaginal incision.

5. The method of claim 1 comprising anchoring two projections to a right obturator foramen and anchoring two projections to a left obturator foramen.

6. The method of claim 1 wherein the implant comprises a continuous length of mesh material forming the major portion and the at least two projections between the anchors, and the length is fixed.

7. The method of claim 1 wherein the anchor comprises non-mesh material.

8. The method of claim 1 wherein the anchor is shaped to preferentially allow movement through tissue in a first direction and to resist movement in an opposite direction.

9. A method for treating incontinence, the method comprising:

providing an implant comprising a synthetic mesh material having at least two projections, each projection comprising an anchor at an end of the projection for associating the implant with an insertion needle,

the anchor shaped preferentially allow movement through tissue in a first direction and to resist movement in an opposite direction,

placing the implant in a position to support a urethra or a bladder neck,

anchoring the anchor of one projection to a right obturator foramen, and

anchoring the anchor of another projection to a left obturator foramen.

10. The method of claim 9 wherein the implant comprises a continuous length of mesh material forming the major portion and the at least two projections between the anchors, and the length is fixed.

11. A method for treating a pelvic health disorder, the method comprising:

providing an implant comprising a synthetic mesh material having a major portion adapted to be positioned to support tissue of a pelvic region and at least four projections extending from the major portion, the implant comprising an anchor at an end of each projection,

positioning the major portion to support tissue selected from vaginal tissue, tissue of the urethra, and tissue of the bladder neck,

extending two projections to a right obturator foramen and anchoring the anchors of the two projections in the right obturator foramen, and

extending two projections to a left obturator foramen and anchoring the anchors of the two projections in the left obturator foramen.

12. The method of claim 11 wherein the disorder is selected from incontinence, cystocele, rectocele, enterocele, vaginal vault prolapse, uterine prolapse, and anal prolapse.

13. The method of claim 11 wherein the implant comprises a continuous length of mesh material forming the major portion and the at least two projections between the anchors, and the length is fixed.

14. The method of claim 11 wherein the anchor is shaped to preferentially allow movement through tissue in a first direction and to resist movement in an opposite direction.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →